SCHIMMEL PAUL 4
4 · aTYR PHARMA INC · Filed Feb 11, 2020
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
SCHIMMEL PAUL
Director
Transactions
- Purchase
Common Stock
2020-02-10$4.25/sh+254,000$1,079,500→ 437,590 total(indirect: See Footnote)
Holdings
- 2,890
Common Stock
- 63,023(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Represents shares purchased in an underwritten public offering at a public offering price of $4.25 per share.
- [F2]There shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
- [F3]These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.